Dimensional Fund Advisors
TXMD icon

Dimensional Fund Advisors’s TherapeuticsMD TXMD Stock Holding History

Dimensional Fund Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.6K Buy
+10,706
New +$24.1K ﹤0.01% 3204
2024
Q2 		– Sell
-10,154
Closed -$23.3K – 3411
2024
Q1 		$23.3K Hold
10,154
– – ﹤0.01% 3361
2023
Q4 		$22.8K Hold
10,154
– – ﹤0.01% 3383
2023
Q3 		$30.7K Buy
+10,154
New +$38.4K ﹤0.01% 3417

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's TXMD Position: Q1 2026 in Review

Dimensional Fund Advisors opened a new position in TherapeuticsMD (TXMD) in Q1 2026: 10,706 shares worth $21.6K. The stake represents ﹤0.01% of the portfolio and ranks #3204 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in TXMD as recently as Q1 2024.

Dimensional Fund Advisors first reported a position in TXMD in Q3 2023 and has held it in 4 quarters since. The position peaked at $30.7K in Q3 2023. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

  • Dimensional Fund Advisors held 10,706 shares of TherapeuticsMD worth $21.6K as of Q1 2026.
  • TherapeuticsMD was a new Dimensional Fund Advisors position in Q1 2026.
  • TherapeuticsMD made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3204 holding.
  • Dimensional Fund Advisors first reported a position in TherapeuticsMD in Q3 2023 and has held it in 4 quarters since.
  • Dimensional Fund Advisors's TherapeuticsMD position peaked at $30.7K in Q3 2023.
  • 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.